Staten Island, NY, United States of America

Roy Henry Mosher

This inventor holds 2 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, University of Alberta. Active years: 2005-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roy Henry Mosher. Retrieved from https://idiyas.com/inventor/roy-henry-mosher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2005-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Roy Henry Mosher: Innovator in Bacterial Genetics

Introduction

Roy Henry Mosher is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of bacterial genetics, particularly in the production of clavulanic acid. With a total of 2 patents, his work has had a meaningful impact on biotechnology.

Latest Patents

Mosher's latest patents include innovative developments in bacterial genes and microorganisms. One of his key patents focuses on novel bacterial genes, microorganisms, and processes for improving the manufacture of 5R clavams, such as clavulanic acid. Additionally, he has isolated DNA that comprises one or more genes specific for 5S clavam biosynthesis, along with vectors that include such DNA and streptomyces hosts capable of enhanced clavulanic acid production.

Career Highlights

Throughout his career, Mosher has worked with prominent organizations, including SmithKline Beecham Corporation and the University of Alberta. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Some of his notable coworkers include John Patrick Griffin and Susan E. Jensen. Their collaborative efforts have further enriched the research landscape in which Mosher operates.

Conclusion

Roy Henry Mosher's contributions to bacterial genetics and his innovative patents highlight his role as a key figure in biotechnology. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…